// App-Quantinova.ai

987 : EAACI Task Force Logogram: Anaphylaxis decision tools to facilitate the diagnosis and management of anaphylaxis in primary care

Researchers

Presenter

  • Mamodaly M

Principal Investigators

  • Gaudin C

  • Kocks J

  • Van Der Velde J

  • FlokstraDe Blok B

  • Gawlik R

  • Romberg K

  • Dermot R

  • Demoly P

  • Kase Tanno L

  • Angier E

Medical Centers

  • University Hospital Montpellier, Montpellier, France

  • General Practitioners Research Institute, Groningen, Netherlands

  • University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, Netherlands

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • University of Groningen, University Medical Centre, Department of General Practice and Elderly Care Medicine, Groningen, the Netherlands

  • University of Groningen, University Medical Centre Groningen, Beatrix Children's Hospital, Department of Paediatric Pulmonology and Paediatric Allergology, Groningen, The Netherlands

  • Health Care Center, Näsets Läkargrupp, Höllviken, Respiratory Medicine and Allergology, Clinical Sciences Lund, Lund, Sweden

  • The University of Edinburgh, Edinburgh, United Kingdom

  • Sorbonne Université, INSERM UMR‐S 1136, IPLESP, Equipe EPAR, Paris, France

  • WHO Collaborating Centre on Scientific Classification Support, Montpellier, France

  • Academic Unit of Primary Care and Population Science, University of Southampton, Southampton, United Kingdom

Locations

  • France

  • Netherlands

  • Singapore

  • Poland

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Anaphylaxis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A